Hypoxic Exosomes Drive CCL26 in HNSCC - Takeaways - MDSpire

Hypoxic Exosomes Drive CCL26 in HNSCC

Hypoxia-induced vesicles reshape endothelial signaling and may promote tumor-associated phenotypes in head and neck squamous cell carcinoma

  • By

  • Andrea Surnit

  • April 13, 2026

  • 3 min

Share

  • 1

    Hypoxia-induced exosomes from HNSCC cells enhance CCL26 secretion in endothelial cells, promoting tumor-associated phenotypes.

  • 2

    CCL26 neutralization or CCR3 silencing significantly reduced the tumor-promoting effects of hypoxic exosomes.

  • 3

    Increased CCL26 levels were confirmed in hypoxic conditions, correlating with enhanced cell viability, migration, and invasion.

  • 4

    Higher expression of CCL26 and hypoxia-inducible factor 1 alpha was observed in metastatic tumors compared to primary tumors.

  • 5

    The study highlights the need for in vivo validation of findings related to hypoxic exosomes and their effects on tumor biology.

Original Source(s)

Hypoxic Exosomes Drive CCL26 in HNSCC

  • by Andrea Surnit

  • April 13, 2026

Related Content

FDA Approves New First-Line TNBC Regimen

Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.

Cell Aging May Predict Future Disease

Plasma proteomic models of more than 40 cell types were associated with incident Alzheimer's disease, amyotrophic lateral sclerosis, cancer,  and mortality across three large cohorts.

Medical Oddities: When a Brush Beats a Scalpel

This research roundup has brain drama, bleeding control, skin science, and tiny brushes.